JSabari Profile Banner
Joshua Sabari, MD Profile
Joshua Sabari, MD

@JSabari

Followers
2K
Following
2K
Media
28
Statuses
193

Thoracic medical oncologist, Perlmutter Cancer Center NYU Langone Health. Tweets are my own and not medical advice

New York, NY
Joined November 2010
Don't wanna be here? Send us removal request.
@JSabari
Joshua Sabari, MD
15 days
RT @lungoncdoc: Discussing data hot off the press here at #HawaiiLung25. Dr. Joshua Sabari reviews the latest FDA approval of DatoDXd for….
0
2
0
@JSabari
Joshua Sabari, MD
20 days
RT @cure_today: Advancements Reshape Treatment for Non-Small Cell Lung Cancer @JSabari @Perlmutter_CC @jainprantesh @RoswellPark #LungCance….
0
3
0
@JSabari
Joshua Sabari, MD
25 days
RT @lung_connect: 📣 HCPs 📣.Do you treat pts w/ rare alterations of #NSCLC?. Medical Oncologist Dr @JSabari and Debra Montague (President of….
0
1
0
@JSabari
Joshua Sabari, MD
2 months
RT @PeerView: Join Joshua Sabari, MD (@JSabari), Jonathan W. Goldman, MD, Gilberto Lopes, MD, MBA, FASCO (@GlopesMd), Zosia Piotrowska, MD….
0
14
0
@JSabari
Joshua Sabari, MD
2 months
Getting excited for ASCO 2025! Join us Sat, May 31 at The Sheraton Grand Chicago Riverwalk in Chicago 6 Ballroom for #PrecisionMedicine in #NSCLC at #ASCO25! 6:30 PM CDT Reg & Dinner | 7 PM CDTSymposium. @PeerView @LUNGevity @OncBrothers ➡️
0
18
26
@JSabari
Joshua Sabari, MD
2 months
Real World Data on Overall Survival in EGFR mutant NSCLC treated with first line Osimertinib @Perlmutter_CC @nyulangone @JTOonline .
2
18
64
@JSabari
Joshua Sabari, MD
4 months
Excited to work with CURE as the new editor in chief! Thank you @DrDebuTripathy for your vision. CURE magazine provides cutting edge advancements for patients with cancer, families and caregivers.@Perlmutter_CC @MDAndersonNews @cure_today
0
2
12
@JSabari
Joshua Sabari, MD
10 months
RT @jillfeldman4: Our goal is to help early career investigators foster collaborations early in their careers and support their important w….
0
16
0
@JSabari
Joshua Sabari, MD
1 year
RT @Medscape: 🚨24 Hours to go until @JSabari and @mvnegrao delve into the latest NSCLC data presented in Chicago! Calling all thoracic onco….
0
1
0
@JSabari
Joshua Sabari, MD
1 year
RT @StephenVLiu: PALOMA-3 results @JCO_ASCO after #ASCO24 oral presentation. Subcutaneous vs intravenous amivantamab (with lazertinib) in p….
0
34
0
@JSabari
Joshua Sabari, MD
1 year
What an amazing experience discussing practice changing lung cancer abstracts #ASCO24 with @OncBrothers @Perlmutter_CC @NYUGSOM_HemeOnc @nyulangone.
@OncBrothers
Oncology Brothers
1 year
Lung Ca Highlights from #ASCO24 w/ @JSabari . - #LAURA.- #MARIPOSA+#PALOMA3.- #CROWN.- #ADRIATIC . Full 🗣️ .- - - The “Oncology Brothers” podcast . #lcsm @ASCO #OncTwitter #MedTwitter @TargetedOnc @jillfeldman4 @EGFRResisters
0
2
15
@JSabari
Joshua Sabari, MD
1 year
RT @OncBrothers: Lung Ca Highlights from #ASCO24 w/ @JSabari . - #LAURA.- #MARIPOSA+#PALOMA3.- #CROWN.- #ADRIATIC . Full 🗣️ .- https://t.co….
0
22
0
@JSabari
Joshua Sabari, MD
2 years
Stay “cure-ious” @VamsiVelcheti. We NEED better perioperative approaches that will lead to more cures in our patients with early stage NSCLC. Two lung cancer Giants in the same shot. @OncLiveSOSS @Perlmutter_CC
Tweet media one
1
2
11
@JSabari
Joshua Sabari, MD
2 years
Don’t miss it! Join us @OncLiveSOSS Lung Cancer @Perlmutter_CC @VamsiVelcheti @ElaineShumMD @salmanpunekar @sallylau @abrahamchachoua @nyulangone Thursday December 14th, 2023 6-9PM Martinique New York on Broadway, 49 W 32 St.
0
1
6
@JSabari
Joshua Sabari, MD
2 years
RT @EGFRSummit: ⏰ NEW DEADLINE ALERT ⏰. Hurry, it's your final shot! Submit your abstract for #EGFRSummit by 9/11. SUBMIT HERE: https://t.….
0
9
0
@JSabari
Joshua Sabari, MD
2 years
RT @CancerNetwrk: .@AlexSpiraMDPhD led a panel of experts to discuss current treatment options for patients with EGFR exon 20 non–small cel….
0
1
0
@JSabari
Joshua Sabari, MD
2 years
RT @rohit_thum: Our study of clinical/genomic predictors of response and toxicity to sotorasib in KRAS G12C+ NSCLC we recently presented at….
0
9
0
@JSabari
Joshua Sabari, MD
2 years
RT @Perlmutter_CC: Treating patients with KRAS-mutant lung cancer and untreated CNS metastasis with Adagrasib shows promising intracranial….
0
2
0
@JSabari
Joshua Sabari, MD
2 years
RT @RielyMD: Nice to see this in print. Cohort of patients with KRAS G12C NSCLC with untreated brain metastases prospectively enrolled and….
0
12
0
@JSabari
Joshua Sabari, MD
3 years
RT @bsabari: Excited to share the first paper from my lab. We show that condensates composed of the disordered region of MED1 selectively p….
0
59
0